Liabilities / Assets
57th percentile
Tied with the lowest-debt nonprofits in its peer group.
Kappa Therapeutics
990EZ • Fiscal year 2018 • EIN 46-0688971
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
56th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
41st percentile
Higher net margin than 41% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
47th percentile
Faster asset growth than 47% of similar nonprofits.
Revenue Growth
1st percentile
Faster revenue growth than 1% of similar nonprofits.
Balance Sheet
Assets
Up$19,282
Up $1 (+0.0%) from 2017
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Flat$0
Flat from 2017
Revenue And Expenses
Revenue
Down$10
Down $28,153 (-100%) from 2017
Expenses
Down$10
Down $32,482 (-100%) from 2017
Net Income
Up$0
Up $4,329 (+100%) from 2017
Historical Trend
Filing Detail Status
This 2018 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2018 to Dec 31, 2018
Mission and Program Overview
Mission
Organize a biannual scientific conference (in 2025, the Kappa Therapeutics Conference was held in St Louis, MO 3/19/2025 - 3/24/2025) (https://kappatherapeutics.org/). In 2025, we also organized a conference on "Stress, Pain, Emotion, Addiction, and Reward" at Friday Harbor, WA (2/10-11/2025) (http://depts.washington.edu/uwnape/2025-spear-conference-at-friday-harbor-labs/). We met at the Society for Neuroscience Conference in San Diego, CA, to plan future meetings.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2018 • Form 990EZSummary only. Only limited summary data is available for this year.
- Assets
- $19,282
- Liabilities
- $0
- Net assets
- -
- Revenue
- $10
- Expenses
- $10
- Net income
- $0